Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 proof-of-concept study of PD 0299685 in interstitial cystitis/painful bladder syndrome
2008-002421-37Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) comparing PD 0299685 with Placebo (2 arms). Primary endpoint: Change from baseline to Week 12 in worst daily pain severity score. Started Jul 2008; status: completed.
02
Drugs
PD-0299685
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on 2008-002421-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002421-37.